Hillstream BioPharma is a biotechnology company developing a focused portfolio of therapeutic candidates targeting drug-resistant and devastating cancers. The company’s emerging immuno-oncology pipeline is led by HSB-3215.

The company recently teamed up with Minotaur Therapeutics to license one of its key technologies. The tech will allow Hillstream to create more targeted and efficient therapies and advance its drug pipeline more rapidly.